Adaptin Bio (APTN) Other Operating Expenses (2025)
Adaptin Bio's (APTN) quarterly Other Operating Expenses came in at -$180000.0 in Q2 2025.
Analysis
Adaptin Bio (APTN) Other Operating Expenses (2025) Analysis & Trends
Adaptin Bio has disclosed Other Operating Expenses across 1 years of filings, most recently posting -$180000.0 for Q2 2025.
- In Q2 2025, Other Operating Expenses changed N/A year-over-year to -$180000.0; the TTM figure through Mar 2026 stood at -$180000.0 (changed N/A YoY), while the FY2025 annual figure was -$180000.0, changed N/A from the prior year.
- Other Operating Expenses came in at -$180000.0 for Q2 2025 at Adaptin Bio.
- In the past five years, Other Operating Expenses ranged from a high of -$180000.0 in Q2 2025 to a low of -$180000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.98 Bn | 1.81 Bn | 56.40 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - |